KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Goodwill (2016 - 2025)

Historic Goodwill for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $6.5 billion.

  • Biogen's Goodwill rose 18.83% to $6.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $6.5 billion, marking a year-over-year increase of 18.83%. This contributed to the annual value of $6.5 billion for FY2025, which is 18.83% up from last year.
  • According to the latest figures from Q4 2025, Biogen's Goodwill is $6.5 billion, which was up 18.83% from $6.5 billion recorded in Q3 2025.
  • In the past 5 years, Biogen's Goodwill ranged from a high of $6.8 billion in Q3 2023 and a low of $5.7 billion during Q3 2022
  • Its 5-year average for Goodwill is $6.1 billion, with a median of $6.0 billion in 2021.
  • Per our database at Business Quant, Biogen's Goodwill skyrocketed by 1857.28% in 2023 and then tumbled by 472.57% in 2024.
  • Over the past 5 years, Biogen's Goodwill (Quarter) stood at $5.8 billion in 2021, then decreased by 0.21% to $5.7 billion in 2022, then grew by 8.18% to $6.2 billion in 2023, then rose by 4.18% to $6.5 billion in 2024, then rose by 0.19% to $6.5 billion in 2025.
  • Its Goodwill was $6.5 billion in Q4 2025, compared to $6.5 billion in Q3 2025 and $6.5 billion in Q2 2025.